Tuberculosis - Drug resistance in Canada 2009

[Previous] [Table of Contents] [Next]

Figures

Figure 1
Reported TB drug resistance in Canada by province/territory – 2009

Figure 1- text equivalent

Figure 2
Reported Mycobacterium tuberculosis isolates in Canada by province/territory– 2009

Figure 2 - text equivalent

Figure 3
Overall pattern of reported TB drug resistance in Canada – 2009

Figure 3 - text equivalent

* Multidrug-resistance TB (MDR-TB) is resistance to at least isoniazid and rifampin.
† Extensively drug-resistant TB (XDR-TB) is MDR-TB plus resistance to any fluoroquinolone and at least 1 of 3 injectable second-line drugs: amikacin, capreomycin and kanamycin.

Figure 4
Reported TB drug resistance in Canada by type of drug – 2009

Figure 4 - text equivalent

Figure 5
Any resistance by type of drug as a percentage of isolates tested: 1999-2009

Figure 5 - text equivalent

Figure 6
Overall pattern of reported TB drug resistance as a percentage of isolates tested – 1999-2009

 

Figure 6 - text equivalent

* Multidrug-resistance TB (MDR-TB) is resistance to at least isoniazid and rifampin.
† Extensively drug-resistant TB (XDR-TB) is MDR-TB plus resistance to any fluoroquinolone and at least 1 of 3 injectable second-line drugs: amikacin, capreomycin, and kanamycin.

[Previous] [Table of Contents] [Next]